FIELD: medicinal and veterinary virology. SUBSTANCE: capsicoside is used for rotaviruses inactivation. Inactivation of virus-containing material is carried out by addition of capsicoside at final concentration 0.005% and above, and mixture is kept at the room temperature for 1 hr and more. Development of virulicide action of preparation is controlled by disappearance of virus infection on the cultured cell СПЭВ. EFFECT: increased effectiveness of inhibitor. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR ROTAVIRUS INACTIVATION | 1992 |
|
RU2057177C1 |
| INHIBITOR OF HUMAN AND ANIMAL ENTEROVIRUSES | 1991 |
|
RU2026346C1 |
| AGENT FOR ESTIMATION OF POLIOMYELITIS VIRUS ATTENUATION DEGREE | 1992 |
|
RU2064794C1 |
| NUTRIENT MEDIUM FOR HUMAN AND ANIMAL CELLS CULTIVATION | 1992 |
|
RU2057176C1 |
| METHOD OF HUMAN CULTURE ROTAVIRUS INACTIVATION | 2019 |
|
RU2738404C1 |
| METHOD OF HUMAN ROTAVIRUS ADAPTATION TO GROWTH ON TRANSPLANTATED ANIMAL CELL CULTURES | 2018 |
|
RU2692604C1 |
| Method of human culture rotavirus inactivation | 2020 |
|
RU2743300C1 |
| MARKER FOR ESTIMATING ATTENUATION OF POLIOMYELITIS VIRUSES | 0 |
|
SU1799598A1 |
| METHOD OF SERODIAGNOSIS OF THE COXSACKIE B VIRUS INFECTION | 0 |
|
SU1714509A1 |
| ALEKSEEVSKIY STRAIN OF SWINEPOX VIRUS FOR VIROLOGICAL, MOLECULAR-GENETIC, MONITORING STUDIES, PRODUCTION OF VACCINES AND DIAGNOSTIC PREPARATIONS | 2013 |
|
RU2560569C2 |
